PATH-53. EXPRESSION BASED INTRINSIC GLIOMA SUBTYPES ARE PROGNOSTIC IN LOW GRADE GLIOMAS OF THE EORTC22033-26033 CLINICAL TRIAL

INTRODUCTION: The EORTC22033-26033 clinical trial investigated whether initial temozolomide (TMZ) chemotherapy confers a survival advantage compared to radiotherapy (RT) in high-risk low-grade glioma patients. The aim of this study was to identify markers associated with survival and treatment respo...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neuro Oncol
Glavni autori: French, Pim, Gao, Ya, Weenink, Bas, van den Bent, Martin, Erdem-Eraslan, Lale, Kros, Johan, Smitt, Peter Sillevis, Gorlia, Thierry, Stupp, Roger, Hegi, Monika, Baumert, Brigitta
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2017
Teme:
Abstracts
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692010/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.742
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items